延迟双能CT细胞外容积不同成像时间点评估肝纤维化分期的比较
前瞻性研究纳入90例慢性肝病患者,行多期腹部双能CT(含3分钟和5分钟延迟期)及肝活检,计算细胞外容积(ECV)。ECV3 min与肝纤维化分期呈中度正相关(τ=0.478),ECV5 min呈弱正相关(τ=0.352);ECV3 min对显著肝纤维化(S2-4)的诊断准确度显著高于ECV5 min(AUC 0.87 vs 0.79,P=.037),对进展性纤维化(S3-4)和肝硬化(S4)无显著差异。
要点
- 3分钟延迟ECV与肝纤维化分期相关性优于5分钟延迟ECV(τ=0.478 vs 0.352)。
- ECV3 min对显著肝纤维化(S2-4)诊断AUC 0.87,显著高于ECV5 min的0.79。
- 对进展性纤维化(S3-4)和肝硬化(S4),两种延迟时间ECV诊断性能无显著差异。
核心结论
- 双能CT细胞外容积可能对无创肝纤维化分期有一定潜力,3分钟延迟ECV不肯定劣于5分钟延迟ECV。
研究设计与样本
- 前瞻性研究,纳入2021年1月至2021年12月间计划行多期腹部双能CT(含3分钟和5分钟延迟期)及肝活检的慢性肝病患者90例,以肝活检为参考标准。
诊断标准与关键数值
- ECV3 min与肝纤维化分期呈中度正相关(τ=0.478,P<.01),ECV5 min呈弱正相关(τ=0.352,P<.01)。
临床应用与阅片要点
- 3分钟延迟期ECV评估可指导临床治疗决策并提高扫描工作效率,作者认为具有重要临床价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To stage liver fibrosis by using delayed dual-energy CT (DECT) and determine the optimal delay time for acquisition of delayed CT scans.
MATERIALS AND METHODS: This prospective study included patients with chronic liver disease, who were scheduled to undergo multiphase abdominal DECT (including 3-min and 5-min delayed periods) and liver biopsies from January 2021 to December 2021. The iodine densities of the parenchyma and aorta were measured and extracellular volume (ECV) was calculated. Kendall rank correlation was employed to assess the relationship between the ECV and the fibrosis stage. Comparison of ECVs was made for different stages of liver fibrosis. In addition, the diagnostic performances of ECV for staging liver fibrosis were evaluated by using receiver operating characteristic (ROC) curve analysis, and area under the curve (AUC) was calculated.
RESULTS: A total of 90 participants were evaluated, and distributed as follows: 10 in S1, 29 in S2, 25 in S3, and 26 in S4. Both ECV of 3-min delayed (ECV3 min) and 5-min delayed (ECV5 min) showed a positive correlation with the stage of liver fibrosis (ECV3 min: τ = 0.478, P < .01, moderate correlation; ECV5 min: τ = 0.352, P < .01, weak correlation). In terms of diagnostic performances, ECV3 min showed significantly higher diagnostic accuracy than ECV5 min for significant liver fibrosis (S2-4) (AUC: 0.87 vs 0.79, P = .037), but no significant differences were observed for progressive fibrosis (S3-4) (AUC: 0.76 vs 0.71, P = .206) or cirrhosis (S4) (AUC: 0.75 vs 0.74, P = .774).
CONCLUSIONS: DECT ECV may have some potential in noninvasively liver fibrosis staging, ECV3 min is not definitely inferior to ECV5 min.
ADVANCES IN KNOWLEDGE: A 3-min delay for the delayed-phase ECV assessment can guide clinical treatment decisions for patients and enhance the efficiency of scanning work, holding significant clinical value.
引用
- Yu C, Zhou W, Peng Y, et al. Comparison of the different imaging time points in delayed dual-energy CT extracellular volume in assessing the staging of liver fibrosis. Br J Radiol. 2025. PMID: 40711958. doi:10.1093/bjr/tqaf177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。